Patent · US Expired

Method and agent for the therapy of immunocomplex diseases

US4479934A · kind A · utility

14Cited by

0References

1Claims

0Family size

Assignee

Behringwerke Aktiengesellschaft · DE

Inventors

Hans-Harald Sedlacek · Marburg, DE
Friedrich-Robert Seiler · Marburg, DE

Key dates

Filing date	Dec 10, 1979
Grant date	Oct 30, 1984
Priority date	—
Expiry date	Dec 10, 1999

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

What is disclosed is a method for the therapy of immunocomplex diseases with an agent which contains Fc-reagents that react with the Fc-part of the antibody contained in the immunocomplex, but which themselves do not posses an immunologically active Fc-part or an Fc-part capable of being activated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.